CML (Chronic Myeloid Leukemia),Leukemia Efficacy and Safety of BOS vs. IMA in Treating CP Chronic Myeloid leukemia (CML) Mar 27, 2023
CML (Chronic Myeloid Leukemia),Leukemia Efficacy and Safety of Ponatinib+Blinatumomab Combo in CML and ALL Mar 27, 2023
AML (Acute Myeloid Leukemia),Leukemia Molecular Profiling of IDH1-Mutated ND-AML Patients in AGILE Study Mar 23, 2023
AML (Acute Myeloid Leukemia),Leukemia AML Long-term Outcomes After Allo-SCT With Decitabine and Venetoclax Mar 23, 2023
AML (Acute Myeloid Leukemia),Leukemia Phase 3 Viale-a Study: Ven Plus Aza for AML Treatment Mar 23, 2023
AML (Acute Myeloid Leukemia),Leukemia ADMIRAL trial: Gilteritinib vs. Chemotherapy for FLT3-Mutated AML Transplant Outcomes Mar 23, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Ibrutinib Improves OS in CLL Patients ≥65 Years as First-Line Treatment Mar 10, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia 4-Year Follow-Up Data of Ibrutinib and Venetoclax Combo in CLL Patients Mar 10, 2023
